06242018Headline:

Bergen County, New Jersey

HomeNew JerseyBergen County

Email Karen Boe Gatlin Karen Boe Gatlin on LinkedIn Karen Boe Gatlin on Twitter Karen Boe Gatlin on Facebook
Karen Boe Gatlin
Karen Boe Gatlin
Contributor •

PSA Testing and Prostate Cancer

Comments Off

A blood test for Prostate Specific Antigen (PSA) is a routine screening measure for prostate cancer. Prostate cells produce a protein called PSA, and a high PSA level in the blood can be a sign of prostate cancer. The normal range of PSA is 0-4 ng/ml. A PSA greater than 4 may indicate cancer or it may indicate more benign conditions such as enlargement of the prostate or infection. However, the rise of PSA must also be considered, a concept known as “PSA velocity.” A rise of more than .75ng/ml per year indicates possible prostate cancer and warrants referral to a urologist or biopsy, regardless of whether the PSA is in the range of 0-4 ng/ml. The concept was developed specifically to enable physicians to identify a certain percentage of men who develop prostate cancer but do not have PSA levels above 4 ng/ml. By using PSA velocity, these cancers can be identified early and treated.

For more information on this subject, please refer to the section on Medical Malpractice and Negligent Care.